14-day Premium Trial Subscription Try For FreeTry Free
$1.37
+0.0100 (+0.735%)
At Close: Apr 23, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.31 $2.47 Tuesday, 23rd Apr 2024 AKBA stock ended at $1.37. This is 0.735% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 4.44% from a day low at $1.35 to a day high of $1.41.
90 days $1.31 $2.47
52 weeks $0.650 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Mar 17, 2023 $0.700 $0.703 $0.635 $0.635 1 466 987
Mar 16, 2023 $0.700 $0.730 $0.675 $0.713 790 321
Mar 15, 2023 $0.664 $0.699 $0.612 $0.672 1 418 002
Mar 14, 2023 $0.760 $0.774 $0.682 $0.683 2 263 603
Mar 13, 2023 $0.773 $0.82 $0.733 $0.755 1 495 236
Mar 10, 2023 $0.780 $0.82 $0.711 $0.799 1 825 714
Mar 09, 2023 $0.83 $0.86 $0.720 $0.80 6 913 431
Mar 08, 2023 $0.94 $1.08 $0.94 $1.03 3 041 570
Mar 07, 2023 $0.95 $0.95 $0.92 $0.95 1 283 829
Mar 06, 2023 $0.96 $0.96 $0.92 $0.94 1 165 994
Mar 03, 2023 $0.92 $0.98 $0.92 $0.97 1 610 682
Mar 02, 2023 $0.86 $1.00 $0.86 $0.93 1 609 461
Mar 01, 2023 $0.81 $0.96 $0.81 $0.91 3 199 979
Feb 28, 2023 $0.784 $0.85 $0.784 $0.84 846 819
Feb 27, 2023 $0.82 $0.88 $0.781 $0.82 2 102 616
Feb 24, 2023 $0.87 $0.87 $0.781 $0.83 6 439 734
Feb 23, 2023 $0.730 $0.770 $0.655 $0.740 3 487 319
Feb 22, 2023 $0.674 $0.719 $0.670 $0.692 1 419 344
Feb 21, 2023 $0.82 $0.85 $0.620 $0.654 3 934 957
Feb 17, 2023 $0.84 $0.89 $0.81 $0.88 1 034 084
Feb 16, 2023 $0.88 $0.89 $0.84 $0.86 542 377
Feb 15, 2023 $0.89 $0.91 $0.81 $0.89 1 544 495
Feb 14, 2023 $0.764 $0.85 $0.764 $0.85 1 149 023
Feb 13, 2023 $0.85 $0.90 $0.751 $0.793 1 929 982
Feb 10, 2023 $1.06 $1.11 $0.570 $0.80 14 803 232
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Golden Star

Ticker Date Change Price
FTSL Apr 18 0.130% $46.22
LNG Apr 17 2.33% $156.81
FCN Apr 16 1.98% $207.62
ELV Apr 16 4.98% $506.97
AKR Apr 05 5.38% $16.53
ITCI Apr 05 8.91% $68.44
SARK Mar 28 17.19% $26.88
ARCC Mar 25 2.68% $20.12
CCK Mar 20 2.77% $77.29
STT Mar 19 2.60% $72.62
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT